Registered entities
Spyre Therapeutics, Inc.
Reg. No. 1636282United States
Social engagement
Social engagement: 17.4K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
15 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 53% |
| Private equity | 2 | 13% |
| Other / undisclosed | 5 | 33% |
Recent activity
16 Jun 2026
Event
EULAR2026
5 Jun 2026
Recognition
3 Jun 2026
Event
2026 European Congress of Rheumatology (#EULAR)